Established in 2014 with a gift of $10 million from the foundation, the fund has supported clinical and research efforts in genomics, heart health, neonatology, and injury prevention and, with the new gift, plans to expand its support for pediatric cancer research. In 2016, the hospital recruited world-renowned genomics researchers Richard K. Wilson and Elaine R. Mardis to lead the Institute for Genomic Medicine at Nationwide Children's research institute, where they have since introduced innovative genomics-based testing and initiated new research initiatives in several disciplines. With the fund's support, more than two hundred and fifty families have received clinical genomics testing and more than fifty pediatric cancer patients have been evaluated using genome sequencing to identify tumor-specific vulnerabilities that may suggest new treatment directions.
The latest gift — which boosts the foundation's total giving to Nationwide Children's Hospital to $100 million — will enable more patients and their families to receive genomic testing.
"The Nationwide Foundation has a longstanding commitment to helping the hospital provide top-ranked clinical care for children in our communities," said Steve Rasmussen, CEO of Nationwide and chair of the Nationwide Foundation. "Our partnership supports efforts to attract world-renowned doctors and researchers who are making significant strides with innovative medical treatment for children around the world. The advances being made in genomic research are potentially life-changing, and it's heartening to know that many children and families will benefit from this work."